Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$121.16
-3.0%
$121.56
$112.31
$212.00
$3.98B1.33627,425 shs114,020 shs
Envista Holdings Corporation stock logo
NVST
Envista
$24.17
-0.5%
$26.53
$16.41
$30.42
$3.95B0.922.83 million shs1.27 million shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$68.93
-5.4%
$114.04
$68.00
$156.00
$2.38B2.07993,962 shs826,896 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$16.04
-13.2%
$21.32
$9.98
$29.65
$1.10B1.641.91 million shs1.83 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
+6.09%-3.32%+5.26%-14.74%-8.38%
Envista Holdings Corporation stock logo
NVST
Envista
-10.05%-6.06%-3.31%-16.31%+44.96%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-0.03%-27.67%-32.07%-46.02%-23.98%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+2.44%-5.38%+1.04%-3.65%-17.03%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$121.16
-3.0%
$121.56
$112.31
$212.00
$3.98B1.33627,425 shs114,020 shs
Envista Holdings Corporation stock logo
NVST
Envista
$24.17
-0.5%
$26.53
$16.41
$30.42
$3.95B0.922.83 million shs1.27 million shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$68.93
-5.4%
$114.04
$68.00
$156.00
$2.38B2.07993,962 shs826,896 shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$16.04
-13.2%
$21.32
$9.98
$29.65
$1.10B1.641.91 million shs1.83 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
+6.09%-3.32%+5.26%-14.74%-8.38%
Envista Holdings Corporation stock logo
NVST
Envista
-10.05%-6.06%-3.31%-16.31%+44.96%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-0.03%-27.67%-32.07%-46.02%-23.98%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
+2.44%-5.38%+1.04%-3.65%-17.03%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2.93
Moderate Buy$193.3859.62% Upside
Envista Holdings Corporation stock logo
NVST
Envista
2.40
Hold$28.8319.28% Upside
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.50
Moderate Buy$135.0095.86% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.55
Moderate Buy$30.1688.08% Upside

Current Analyst Ratings Breakdown

Latest TNDM, NVST, IRTC, and TMDX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Set Price Target$24.00
5/7/2026
Envista Holdings Corporation stock logo
NVST
Envista
Reiterated RatingOutperform$33.00
5/7/2026
Envista Holdings Corporation stock logo
NVST
Envista
Boost Price TargetNeutral$26.00 ➝ $29.00
5/7/2026
Envista Holdings Corporation stock logo
NVST
Envista
Boost Price TargetOutperform$30.00 ➝ $31.00
5/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Lower Price TargetBuy$152.00 ➝ $124.00
5/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Lower Price TargetBuy$190.00 ➝ $120.00
5/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Lower Price TargetHold$130.00 ➝ $85.00
5/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Lower Price TargetOverweight$160.00 ➝ $120.00
5/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Lower Price TargetBuy$174.00 ➝ $142.00
5/6/2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
DowngradeOutperformMarket Perform
5/4/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Boost Price TargetBuy$155.00 ➝ $157.00
(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$787.85M5.05N/AN/A$4.91 per share24.68
Envista Holdings Corporation stock logo
NVST
Envista
$2.72B1.45$1.94 per share12.47$18.89 per share1.28
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$605.49M3.93$3.71 per share18.57$14.29 per share4.82
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$1.01B1.08N/AN/A$2.29 per share7.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$44.55M-$0.86N/A92.48N/A-3.53%-10.26%-1.39%N/A
Envista Holdings Corporation stock logo
NVST
Envista
$47M$0.2859.0615.591.852.41%7.09%3.90%N/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$190.29M$4.9015.6718.00N/A27.04%22.38%8.46%N/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$204.71M-$3.07N/AN/AN/A-20.17%-68.23%-11.07%N/A

Latest TNDM, NVST, IRTC, and TMDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.46-$0.30+$0.16-$0.30$240.41 million$247.22 million
5/6/2026Q1 2026
Envista Holdings Corporation stock logo
NVST
Envista
$0.31$0.36+$0.05$0.23$680.04 million$705.50 million
5/5/2026Q1 2026
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.62$0.30-$0.32$0.20$174.44 million$173.93 million
4/30/2026Q1 2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$0.56-$0.35+$0.21-$0.43$194.11 million$199.39 million
2/19/2026Q4 2025
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$0.02$0.29+$0.27$0.17$202.61 million$208.89 million
2/19/2026Q4 2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.05-$0.01+$0.04-$0.01$277.14 million$290.38 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
Envista Holdings Corporation stock logo
NVST
Envista
N/AN/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
4.03
5.17
4.98
Envista Holdings Corporation stock logo
NVST
Envista
0.47
2.38
2.04
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
1.70
6.74
6.59
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.00
2.55
2.02

Institutional Ownership

CompanyInstitutional Ownership
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A
Envista Holdings Corporation stock logo
NVST
Envista
N/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.98%
Envista Holdings Corporation stock logo
NVST
Envista
0.99%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
6.90%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,40032.86 million32.54 millionOptionable
Envista Holdings Corporation stock logo
NVST
Envista
12,000162.98 million161.37 millionOptionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
21034.56 million32.15 millionOptionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,50068.50 million67.07 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$121.16 -3.72 (-2.98%)
As of 11:06 AM Eastern
This is a fair market value price provided by Massive. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Envista stock logo

Envista NYSE:NVST

$24.17 -0.12 (-0.49%)
As of 11:06 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

TransMedics Group stock logo

TransMedics Group NASDAQ:TMDX

$68.93 -3.97 (-5.45%)
As of 11:06 AM Eastern
This is a fair market value price provided by Massive. Learn more.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Tandem Diabetes Care stock logo

Tandem Diabetes Care NASDAQ:TNDM

$16.04 -2.44 (-13.18%)
As of 11:06 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.